, 2007 and Rodrigues and Sapolsky, 2009)


, 2007 and Rodrigues and Sapolsky, 2009).

Interestingly, blocking noradrenergic activity after cued aversive learning training does not impair the consolidation of fear learning (Bush et al., 2010, Debiec and LeDoux, 2004 and Lee et al., 2001), suggesting that noradrenergic release during training alone is sufficient to facilitate consolidation. However, noradrenergic activity appears to be necessary for the enhancing effects of stress-induced Selleck PI3K inhibitor glucocorticoids on fear learning as blocking noradrenaline during concurrent administration of glucocorticoids into the amygdala impairs cued fear memory enhancements seen with glucocorticoid adminstration alone (Roozendaal et al., 2006). This is consistent with the notion that noradrenergic signaling in the amygdala facilitates the acquisition (i.e., within-session

performance) of fear learning independently of glucocorticoids, while the consolidation of such learning relies critically on glucocorticoid activity that works synergistically with noradrenaline (Rodrigues et al., 2009). Surprisingly few studies have examined the effects of stress on cued fear learning in humans. One study showed that stress induced an hour before fear conditioning facilitated acquisition in male participants but not females (Jackson et al., 2006). Another reported that high levels of endogenous glucocorticoids (i.e., cortisol) after stress enhanced fear memory consolidation as measured by retrieval one day later (Zorawski et al., 2006). A recent study in men (Antov et al., 2013) demonstrated that stress administered prior to fear conditioning did not alter fear acquisition relative to non-stressed controls. Although group differences Imatinib did not emerge, the interval of time between the stressor and fear conditioning task did influence the effects of stress hormones on conditioned responses as measured by skin conductance. Specifically, stress administered 10 min before fear conditioning resulted in a positive association between conditioned responses and features of sympathetic nervous system arousal (i.e., blood pressure increase), consistent with the rapid noradrenergic effects typically reported

directly after stress exposure. In contrast, conditioning after a longer delay of 50 min led to a negative association between unless conditioned responses and cortisol, suggesting that HPA-axis responses at longer timescales may facilitate the recovery of a stressful experience by attenuating fear responses, as has been suggested previously (see Hermans et al., 2014 for review). Despite significant progress identifying the temporal and contextual factors that influence the learning and retention of extinction, limited studies have investigated the effects of stress on this method of fear inhibition, especially in humans. Research in non-human animals, however, has provided some insight into how these processes, along with the neural circuits that support them, may be affected by acute stress.

Posted in Antibody | Leave a comment

L’élimination de la population T CD8+/CD57+

L’élimination de la population T CD8+/CD57+ PF-01367338 research buy induit ainsi une augmentation du nombre de colonies de CFU-GM et BFU-E et à l’inverse sa réintroduction diminue le nombre de ces colonies. Ce phénomène d’inhibition est restreint par le CMH de classe II (HLA-DR2) car il peut être prévenu par un anticorps monoclonal spécifique de cette classe de molécules [41]. L’inhibition de la pousse des CFU pourrait être également exercée

par des lymphocytes T CD8+/CD57+ provenant d’individus normaux [42]. L’effet inhibiteur de cette population sur l’hématopoïèse semble d’ordre allogénique puisqu’il n’est pas observé en cas de greffe de cellules souches hématopoïétiques syngéniques. Les lymphocytes T CD8+/CD57+ ont été associés à la survenue d’alvéolites lymphocytaires dans les réactions du greffon contre l’hôte chroniques, après un délai médian de 210 jours [43]. Ces alvéolites sont particulièrement sensibles aux traitements immunosuppresseurs.

Des épanchements pleuraux et péricardiques lymphocytaires et parfois une anasarque ont été également rapportés [44]. Les lymphocytes T CD8+/CD57+ pourraient également être directement impliqués dans le développement d’une réaction du greffon contre l’hôte en secrétant de l’interféron-γ [45]. Une hyperlymphocytose T CD8+/CD57+ avec une diminution du rapport CD4/CD8 (< 0,9) s’observe chez plus d’un tiers des patients atteints de déficit immunitaire commun variable (DICV) [46]. Chez ces malades, une splénomégalie est plus fréquemment observée que chez les patients avec un rapport CD4/CD8 normal (71 % contre 29 %, respectivement). Dolutegravir mw De plus, un tableau de granulomatose, une anergie et une lymphopénie B plus profonde sont plus

souvent observés [47] and [48]. L’identification d’une expansion T CD8+/CD57+ sanguine au cours d’un DICV associé à une splénomégalie peut donc ainsi être un des éléments d’orientation vers le diagnostic d’infiltration splénique non tumorale plutôt que vers une hémopathie lymphoïde. click here Les neutropénies relevant de mécanismes immunologiques sont de nature très diverses. Les neutropénies auto-immunes, associées à des auto-anticorps dirigés contre les neutrophiles matures et/ou les progéniteurs granuleux médullaires s’observent principalement chez l’enfant, alors qu’elles sont exceptionnelles chez l’adulte (tableau I). Dans les autres cas, elles sont isolées et appelées neutropénies chroniques idiopathiques (ou immunologiques). Ces neutropénies peuvent s’associer à une ou deux autres cytopénies auto-immunes (thrombopénie et/ou anémie hémolytique auto-immune). Elles peuvent s’accompagner d’un cortège d’auto-anticorps suggérant un mécanisme auto-immun. Dans ces situations, la mise en évidence d’anomalies qualitatives ou quantitatives des lymphocytes T CD8+/CD57+ dans la moelle ou le sang peuvent plaider pour un mécanisme immunologique et aident donc au diagnostic étiologique [49] and [50].

Posted in Antibody | Leave a comment

, 2004, Doak et al , 2006, Flodmark et al , 2006, Hardeman et al

, 2004, Doak et al., 2006, Flodmark et al., 2006, Hardeman et al., 2000, NHS Centre for Reviews and Dissemination, 2002, Sharma, 2006, Stice et al., 2006 and Summerbell et al., 2005), encompassing 70 studies. The participants were asked to consider their own intervention ideas and those presented, and prioritise potential elements of an intervention programme in three stages. Focus group schedules are shown in

Table 1. Sessions Selleckchem LY2835219 lasted1–2 h. Audio-recordings were transcribed verbatim. In order to explore perceptions of the causes of childhood obesity, we undertook a thematic analysis. Data were initially coded into emergent themes using NVivo7 computer package. An iterative inductive process was undertaken to identify relationships between themes and distill broad theoretical concepts (Spencer et al., 2003). All transcripts

were reviewed by the two moderators. Thematic coding was undertaken by one moderator, and emergent themes and relationships between them were reviewed by the second moderator. We convened 9 focus groups over 5 months in 2007. There was unavoidable heterogeneity within some groups, including one where a school governor was among a parent group. However, the flow of discussion was comparable to other parent sessions. In total there were 68 participants. The majority were female (60, 88%). this website Of 55 participants disclosing ethnicity, 30 (55%) were from the three South Asian groups. (Table 2). The two overarching themes of influences on the development of childhood obesity to emerge are unhealthy food intake and lack of physical activity. These themes are consistent across a range of contexts which can be grouped into six areas; child, family, culture, school, local environment and macro-environment, although there is much fluidity between these. In terms of the wider environmental influences, most groups discussed the local environmental

context and professional participants explicitly articulated the wider societal view, particularly the influence of food marketing. Parents also implicitly alluded to societal influences through their stories. For example, reference L-NAME HCl was made to media influences, the shift to sedentary lifestyles and the local abundance of fast food/takeaway shops. More proximal factors identified related to child and parental behaviours. For example, participants cited work commitments limiting parental time for food preparation and family activities, and unsafe local environments prompting parents to limit children’s physical activity. Whilst much data is widely applicable, some specific cultural contextual factors serve to explain particular health behaviours in South Asian communities. For example, extended families often live in one dwelling with hierarchical structures that give the grandmother control within the family and influence over the diets of the children.

Posted in Antibody | Leave a comment

It had previously been determined that overhead stirring was not

It had previously been determined that overhead stirring was not suitable for preparation of the HEC-based semi-solids due to the high rate of shear required U0126 manufacturer to achieve uniform mixing, excessive aeration and the potential for high shearing stresses to trigger mechanical breakdown of the polymeric components. To overcome this, mixing was carried out under vacuum with the use of the HiVac® mixing bowl. Following dispensing trials a number of semi-solid formulations

were selected for rheological flow analysis. The influence of shear rate on the shear viscosity of the selected HEC- and NaCMC-based semi-solids is shown in Fig. 1a and b, respectively. Flow analysis showed that all the semi-solid formulations were pseudoplastic in nature in that they displayed decreasing shear viscosity with increasing shear rate. The power law function was used to determine flow consistency (κ) of the materials understudy (at 1 s−1) ( Table 2). On the basis of rheological analysis and dispensing trials, determined by viscosity and ability to settle into blister pack wells, formulations containing Blanose 7LF were chosen for lyophilization. Obeticholic Acid For all semi-solid formulations in the absence and presence of CN54gp140, the glass transition

temperature was identified between −21 and −22 °C. Three solid dosage forms with different dimensions were prepared (Fig. 2a–c). LSDFs containing 10% Blanose 7LF were inconsistent in structure whereas those containing lower levels of Blanose 7LF provided uniform units suitable for further investigation.

Following friability testing no lyophilized solid dosage formulation tested (both those shown in Fig. 2a and b) was subject to fracture or exterior damage. No loss of weight occurred whereas slight increases in weight were detected (<8%). Following reconstitution of the LSDFs designed for i.vag administration (Fig. 2a) in SVF (1 tablet per 1 ml) oscillatory (dynamic) analysis (a measure ADAMTS5 of consistency) was performed on the resulting semi-solid structure at 37 °C and compared to the original equivalent semi-solid formulations pre-lyophilization (Table 2). The percentage cumulative release of CN54gp140 from solid dosage formulations (formulation type – Fig. 2b) containing Blanose 7LF at 3, 5 and 10% is shown in Fig. 3. Release profiles of CN54gp140 were similar, displaying a continuous release of antigen with maximum CN54gp140 detectable (Tmax) in the dissolution media after a 7–8 h period (Table 3). The percentage cumulative release of CN54gp140 from solid dosage formulations (formulation type – Fig. 2c) lyo-PC3HEC250HHX5PVP4, lyo-PC3Blanose7LF3PVP4 and lyo-Carbopol® going forward to the mouse immunogenicity study are shown in Fig. 4. Stability of CN54gp140 within the lyophilized solid dosage tablet formulation (Formulation type – Fig.

Posted in Antibody | Leave a comment

If information from prognostic studies is to be used by clinician

If information from prognostic studies is to be used by clinicians to derive prognoses of patients early after stroke, it is important that prognostic studies recruit representative populations (Herbert et al 2005) seen early after stroke. These include

consecutive cohorts from hospitals or cohorts from registries, rather than a select group of patients included in trials or referred for rehabilitation. It is also important that studies not only identify significant predictors but develop robust and clinically applicable models Staurosporine mouse for external validation. Without external validation, it is not recommended for clinicians to use the prediction models in clinical practice (Moons et al 2009). Studies that have recruited cohorts early after stroke have reported varying estimates of recovery of independent ambulation (41 to 85%) (Dallas et al 2008, Feigin et al 1996, Veerbeek et al 2011, Wade and Hewer 1987, Wandel et al 2000) and upper limb function (32 to 34%) (Au-Yeung and

Hui-Chan 2009, Heller et al 1987, Nijland et al 2010). In addition, some researchers check details have conducted multivariate analyses of data from acute stroke cohorts. These studies reported that pre-morbid function (Wandel et al 2000), strength of leg muscles (Veerbeek et al 2011, Wandel et al 2000), sitting ability (Loewen and Anderson 1990, Veerbeek et al 2011), walking ability and bowel control (Loewen and Anderson 1990) predicted recovery of independent What is already known on this topic: Many studies have identified predictors of recovery of ambulation and upper limb function after stroke. However, few have recruited representative cohorts early after stroke or developed prediction models suitable for external validation. What this study adds: Within six months of stroke, over two-thirds of people who are initially non-ambulant recover

independent ambulation but less second than half of those who initially lack upper limb function recover it. Prediction models using age and NIHSS can predict independent ambulation and upper limb function six months after stroke. External validation of these models is now required. Two prognostic models, one of ambulation and one of upper limb function, were recently developed by one group in the Netherlands and these are potentially at the stage of external validation (Nijland et al 2010, Veerbeek et al 2011). Even though the cohorts do not appear to have been recruited consecutively, recruitment from multiple acute stroke units and high follow-up rates in both studies may make these cohorts more representative than other non-consecutive cohorts. They also reported good predictive accuracy of their models (positive likelihood ratios = 5.24 to 5.

Posted in Antibody | Leave a comment

The fidelity of the product was confirmed by mass spectrometric a

The fidelity of the product was confirmed by mass spectrometric analysis of tryptic fragments, by the Medical Biomics Centre at SGUL. Fourteen UK captive-bred female cynomolgus macaques (Macaca fascicularis), aged between 4 and 5 years at the beginning of the experiment, were housed in accordance with the Home Office (UK) Code of Practice (1989). Animals were sedated with ketamine hydrochloride prior to procedures. Menstrual cycles were determined by the onset of bleeding. Animals were assigned to experimental groups (Table 1). Immunisation timings varied dependent upon individual menstrual cycles. Gp140

was formulated at 100 μg ml−1 in Carbopol gel as described previously [21]. 1 ml of the mixture was administered via a syringe inserted approximately 2 cm into the mTOR inhibitor vagina. For any one cycle of intravaginal inoculation, animals received formulated product on 9 occasions at 2–3 daily intervals during the inter-menses phase of the menstrual Akt inhibitor cycle. For systemic immunisation, 100 μg gp140 was mixed with an equal volume of AS01 adjuvant and 0.2 ml injected into each deltoid

muscle. Secretions were sampled using pre-weighed Weck-cel surgical spears (Medtronic Ophthalmics, Jacksonville, FL) placed either on the cervical os or the vaginal wall for 1 min. After reweighing, secretions were eluted from the sponges as described previously [21]. 8 μl of heat inactivated foetal calf serum was added to pooled extracts before freezing aliquots at −80 °C. Total immunoglobulin concentrations Astemizole in mucosal eluates were measured by sandwich ELISA. 96-well plates (medium binding, Greiner Bio-One, Stonehouse, UK) were coated with either goat anti-monkey IgG (γ-chain-specific) (KPL, Gaithersburg, USA) or goat anti-monkey IgA (α-chain-specific) (KPL) at 2 μg ml−1. After washing and blocking, as detailed below for antibody ELISA, mucosal eluates were added at dilutions of 1/100

and 1/1000. Bound immunoglobulin was detected by addition of goat anti-monkey IgG (Fc-specific) HRP conjugate (AbD Serotec, Kidlington, UK) or goat anti-monkey IgA (Fc-specific) HRP conjugate. Standard curves were derived using purified rhesus monkey IgG (SouthernBiotech, Birmingham, USA) or purified human IgA (Sigma, UK) and concentrations in mucosal secretions calculated taking into account the dilution factor derived from the weight of sample. Due to the unavailability of purified monkey IgA, results for this isotype were expressed as units (U) ml−1. Anti-gp140 binding antibodies were measured using a standardised ELISA. 96-well plates were coated with 50 μl per well of recombinant CN54gp140 at 5 μg ml−1 in PBS for 1 h at 37 °C. After washing four times in PBS containing 0.05% Tween 20 (PBS-T) reactive sites were blocked by incubation with PBS-T containing 10% foetal calf serum for 1 h at 37 °C. After further washing, serial dilutions of serum or mucosal eluates in PBS-T were added and incubated for 1 h at 37 °C.

Posted in Antibody | Leave a comment

India is the largest producer (80%) and exporter (60%) of turmeri

India is the largest producer (80%) and exporter (60%) of turmeric in the world. 1 Turmeric plants are propagated by vegetative method using mother and finger rhizomes. 2 The plant is seasonally affected by few major and minor pests which includes shoot borer, Conogethes punctiferalis

and leaf roller, Udaspes folus 3 and 4 which leads to major crop loss 5 observed U. folus harboring Elettaria cardomum, OSI-744 nmr Aframomum melegueta and Curcuma amada too. The larvae of this lepidopteron pest cause destruction in the plant leaf and cause considerable yield loss by 20–34%. Entomopathogenic fungi like Beauveria bassiana (Bals.) Vuillemin and Metarhizium anisopliae (Metsch.) Sorokin has been used successfully for managing insect pests in temperate regions. 6 The present study was aimed in developing a biopesticide click here against U. folus with rapid growth rate and high pathogenicity. The study was conducted in PTS turmeric variety which is a famous cultivar of India now preferred by most farmers for its high yield and its high tolerance to disease

and pest attack. Neem products are also used selectively in controlling pests of various economically useful plants. 7 The seeds contain a complex secondary metabolite azadirachtin which imparts a bitter taste. It acts as an anti-feedant, repellent and egg-laying deterrent, protecting the crop from damage. Similarly the leaves of Vitex negundo are also capable of causing mortality of lepidopteron pests. 8 So these two plant products were also used in the current study for comparison purpose. To keep in mind on all these parameters, studies were conducted to evaluate indigenous biocontrol agents to control U. folus under field conditions. Surveys were conducted in naturally infected turmeric farms to isolate and identify virulent entomopathogenic fungi infecting U. folus of PTS turmeric plants in Erode region, [11°20 N 77°431 E],

Tamil Nadu, India. The collections were made during September–November in 2010. The cadavers were collected in sterile glass second vials separately from which the pathogens were isolated using Potato Dextrose Agar (PDA) medium following standard mycological techniques. 9 Two fungi were subjected to 18S rDNA sequencing and BLAST and identified as Hirsutella citriformis and Nomuraea rileyi. The fungal sequences were deposited in NCBI (JQ 675289 and JQ 686668; respectively). Along with M. anisopliae and B. bassiana, which are commonly used entomopathogenic fungi; Standard H. citriformis (MTCC 6800) and N. rileyi (MTCC 4171) cultures were obtained from Microbial Type Culture Collection, Chandigarh, India and used for comparison studies. For B. bassiana, H. citriformis and M. anisopliae PDA medium and N. rileyi, Sabarouds Yeast Maltose Peptone (SYMP) medium was used for multiplication. Spore suspensions of each pathogenic fungus were prepared by using 80–100 ml of sterile distilled water containing 0.05% Tween 80 solution.

Posted in Antibody | Leave a comment

An important step that countries can take to encourage well-infor

An important step that countries can take to encourage well-informed decision making regarding immunization is to establish a group of national experts to advise the Ministry of Health. So far, most industrialized countries and some developing countries have already constituted National Immunization Technical Advisory Groups (NITAGs) to guide Everolimus immunization policies [1], while other countries are currently working towards the establishment of NITAGs. The aim of the Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative is to help countries establish or strengthen NITAGs. This support is provided in middle-income

countries and in countries that are eligible for support from the Global Alliance for Vaccines and Immunization (GAVI). The main role of NITAGs is to help health authorities formulate immunization policies according to the specific needs of their country, while taking into account the regional and international context. In addition to supporting countries directly, SIVAC also contributes to activities and products that can benefit a wider range selleck chemical of countries. This project, funded by the Bill & Melinda Gates Foundation, is led by the French agency Agence de Médecine Préventive (AMP), in partnership with the International Vaccine Institute (IVI) of Seoul, Republic of Korea (Table 1), and in collaboration with the

World Health Organization (WHO) through its headquarters and regional

and country offices. The SIVAC team is composed of a program director, a program manager and a program officer based in Paris, France; a coordinator for Asia based in Seoul, Republic of Korea; and a coordinator for West Africa based in Abidjan, Cote d’Ivoire. The principal investigator of the SIVAC Initiative is AMP’s scientific director. There are many other contributors to the project, including technical staff from AMP with specialties in epidemiology, training and communications, health economics, immunization logistics, and vaccine cold chain, as well as IVI staff and consultants about with expertise in translational research and epidemiology. The SIVAC Initiative also benefits from the input of the members of its External Technical Advisory Panel (ETAP). This advisory panel is composed of eleven members, all from different countries, who were selected for their expertise and for their active participation in the establishment and implementation of immunization policies and programs at the national, regional, and international level. Their roles are to advise the SIVAC team and to provide input concerning strategic directions for the project. Initiated in April 2008, the project is planned to end in April 2015. Initially, SIVAC’s objective was to assist in establishing NITAGs in six GAVI-eligible countries in Africa and six GAVI-eligible countries in Asia.

Posted in Antibody | Leave a comment

Payment for rapid review guarantees only an expedited review and

Payment for rapid review guarantees only an expedited review and not acceptance. For potentially acceptable manuscripts, the period between receipt of all reviews and when an editorial decision is made is usually longer. All accepted NIH funded articles must be directly deposited to PubMed Central by the authors of the article for public access 12 months after the publication date. The corresponding author will receive electronic page proofs to check the typeset article before publication. Portable document Alectinib mw format (PDF) files of the typeset pages and support documents (eg reprint order form) will

be sent to the corresponding author by email. Complete instructions will be provided with the email for downloading and printing the files and for faxing the corrected page proofs to the editorial office. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the author’s meaning. Only the most critical changes to the accuracy

of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The editorial office reserves the right RG7204 clinical trial to disallow extensive alterations. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must

be checked carefully and corrections many faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs. The statements and opinions contained in the articles of Urology Practice are solely those of the individual authors and contributors and not of the American Urological Association Education and Research, Inc. or Elsevier Inc. The appearance of the advertisements in Urology Practice is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. The content of this publication may contain discussion of off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. To the extent permissible under applicable laws, no responsibility is assumed by the publisher and by the AUA for any injury and/or damage to persons or property as a result of any actual or alleged libelous statements, infringement of intellectual property or privacy rights, or products liability, whether resulting from negligence or otherwise, or from any use of operation, ideas, instructions, procedures, products or methods contained in the material therein. The AUA requires that prior to participating in programs all individuals make full disclosure of relationships, business transactions, presentations or publications related to healthcare or AUA activities.

Posted in Antibody | Leave a comment

Totally 35 B thuringiensis strains (17strains from plain areas a

Totally 35 B. thuringiensis strains (17strains from plain areas and 18 strains from hilly areas) were subjected to plasmid profiling. Different sizes of plasmids ranging from 108 kb to 2 kb in 97.22% strains were isolated. A major chromosomal DNA band near 23 kb marker band was obtained in all isolates. Each B. thuringiensis strain from Kashmir has shown single

megaplasmid only. While as B. thuringiensis strains from Salem, Tamil Nadu revealed see more 77.77% and 22.22% single and multiple megaplasmids respectively. B. thuringiensis strains isolated from Tamil Nadu hilly areas (Yercaud and Kollimallai) have shown 58.82% and 29.41% single and multiple plasmids respectively. Special care was taken to obtain un-degraded megaplasmids during the purification procedure. Plasmid comparison mainly focused only on those plasmids migrating below the chromosomal DNA band. The present study describes how the RO4929097 purchase plasmid profile is varying and showing diversity in B. thuringiensis isolates from different environmental conditions. B. thuringiensis strains from hilly areas (Yercarud and Kollimalai) have revealed more megaplasmid content (29.41%) compared to the isolates from plain areas (11.76%) of Tamil Nadu and Kashmir. As these megaplasmids harbor cry genes. Thus it can be concluded that isolates from Eastern Ghats of India have good chances of having B. thuringiensis strains with more novel cry genes. All authors

have none to declare. We are highly thankful to Daniel R. Zeigler Ph.D, director BGSC, Department of Biochemistry, Ohio State University Columbus, for providing the references strains. “
“Millions of people in developing countries, for instance Nigeria, use herbal medicines because they are locally available and are prescribed by traditional medicine practitioners who are a part of their community. About

80% of the world population relies on the use of traditional medicine, which is predominantly based on plant material.1 Over 90% of Nigerians in the rural areas and 40% in the urban areas depend partly or wholly on traditional medicine for their health care.1 The use of herbal medicines as complements or alternatives to orthodox medicines has been on the increase. The reasons which have given rise to this trend, include: cheapness, availability and accessibility of these natural medicines.2 On the other hand, their use is limited because those many of the claimed medicinal values have not been scientifically evaluated and their safety profiles uncertain.2 Diarrhoea is defined by,3 as having three or more loose or liquid stools per day, or as having more stools than is normal for a person. Diarrhoea can lead to severe dehydration and become life-threatening when not treated. In developing countries, diarrhoea, which may or may not be infectious, is one of the leading causes of morbidity and mortality in children and one out of every five children dies of diarrhoea before the age of five.

Posted in Antibody | Leave a comment